Drug Information

Drug General Information
Drug ID
D06VGG
Former ID
DNC000841
Drug Name
KT6528
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535806]
Structure
Download
2D MOL

3D MOL
Formula
C26H19N3O6
Canonical SMILES
CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)<br />C(=O)N(C6=O)O)(CO)O
InChI
1S/C26H19N3O6/c1-25-26(33,11-30)10-16(35-25)27-14-8-4-2-6-12(14)17-19-20(24(32)29(34)23(19)31)18-13-7-3-5-9-15(13)28(25)22(18)21(17)27/h2-9,16,30,33-34H,10-11H2,1H3/t16-,25-,26-/m0/s1
InChIKey
KNJUOEDHHOTPLA-LADPQGRPSA-N
CAS Number
CAS 66-97-7
PubChem Compound ID
132714
PubChem Substance ID
29310791, 57344243, 78290684, 104378071, 135088402
ChEBI ID
ChEBI:27616
SuperDrug ATC ID
D05BA03
SuperDrug CAS ID
cas=000484208
Target and Pathway
Target(s) DNA topoisomerase I Target Info Inducer [535806]
WikiPathways Integrated Pancreatic Cancer Pathway
References
Ref 535806Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Biochemistry. 1992 Dec 8;31(48):12069-75.
Ref 535806Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Biochemistry. 1992 Dec 8;31(48):12069-75.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.